Stock Track | Cellebrite Plunges 6.36% in Pre-market as Q1 Net Income Misses Estimates

Stock Track
05/14

Cellebrite's stock fell 6.36% in pre-market trading on Thursday following the release of its first-quarter 2026 financial results.

The digital intelligence company reported quarterly revenue of $128.301 million, slightly above analyst estimates of $126.8 million. Adjusted EBITDA also beat expectations, coming in at $30.617 million versus the $27.2 million estimate. However, the company's net income of $10.938 million significantly missed the Ibes estimate of $23.9 million, which appears to be the primary driver behind the stock's decline.

For the second quarter, Cellebrite provided an outlook for revenue between $130 million and $133 million, and adjusted EBITDA between $29 million and $31 million.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10